Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
FDA clears Lumosity brain training games for adult ADHD
Dubbed LumosityRx, the agency's 510(k) covers the smartphone app's use in improving attention among people between the ages of 22 and 55.
Joseph Keenan
Dec 11, 2025 10:00am
FDA approves 1st nondrug, at-home treatment for depression
Dec 11, 2025 6:00am
FDA clears Francis Medical's water vapor prostate tumor ablation
Dec 10, 2025 9:25am
Teleflex inks $2B in divestment deals for 3 company units
Dec 9, 2025 12:26pm
Medline sets terms for massive $5.37B Nasdaq IPO
Dec 9, 2025 11:19am
FDA clears Resmed AI for personalizing CPAP settings
Dec 8, 2025 11:50am